Table 3.
Progression-free survival | Overall survival | |||||
---|---|---|---|---|---|---|
|
|
|||||
Variable | Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value |
Age (years) | 0.91 | 0.45-1.89 | 0.56 | 1.22 | 0.23-2.81 | 0.61 |
Gender | 0.69 | 0.25-3.27 | 0.69 | 0.97 | 0.48-3.11 | 0.34 |
Smoking history | 1.47 | 0.89-7.28 | 0.09 | 1.83 | 0.72-8.77 | 0.07 |
Weight loss | 1.38 | 0.77-4.81 | 0.12 | 1.69 | 0.79-4.99 | 0.08 |
TNM stage | 4.28 | 3.11-16.2 | 0.001 | 3.37 | 2.21-18.91 | 0.004 |
Regional lymph node involvement | 2.11 | 1.39-5.31 | 0.01 | 1.24 | 0.92-2.49 | 0.07 |
Histology | 1.27 | 0.79-2.97 | 0.57 | 0.93 | 0.49-1.28 | 0.48 |
Differentiation | 3.82 | 0.73-14.78 | 0.06 | 4.77 | 3.62-16.46 | <0.001 |
Surgical margins | 2.09 | 1.88-4.85 | 0.04 | 1.63 | 0.73-6.63 | 0.06 |
MiR-107 | 3.08 | 2.01-8.92 | 0.003 | 2.57 | 1.88-10.28 | 0.007 |